| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 From the Department of Clinical Pharmacology; the 2 Institute of Medical Physics; and the 3 Department of Ophthalmology, Vienna University, Austria.
PURPOSE. There is evidence from animal studies that nitric oxide (NO) is a major determinant of ocular blood flow. In humans NO synthase inhibition reduces pulsatile choroidal blood flow, but no data on optic nerve head (ONH) vasculature are available yet. The goal of this study was to investigate the effects of NO synthase inhibition on human choroidal and ONH blood flow using laser Doppler flowmetry.
METHODS. The study design was a randomized, placebo-controlled, double-masked, balanced three-way crossover. On separate study days 12 healthy male subjects received infusions of NG-nitro-L-arginine (L-NMMA; either 3 mg/kg over 5 minutes followed by 30 µg/kg per minute over 55 minutes or 6 mg/kg over 5 minutes followed by 60 µg/kg per minute over 55 minutes) or placebo. The effects of L-NMMA or placebo on choroidal and ONH blood flow were measured with laser Doppler flowmetry. In addition, laser interferometric measurement of fundus pulsation was performed in the macula to assess pulsatile choroidal blood flow.
RESULTS. L-NMMA reduced all outcome parameters in the choroid and the ONH. The higher dose of L-NMMA caused a significant decrease in blood flow in the choroid (-26% ± 9%; P < 0.001) and the ONH (-20% ± 16%; P < 0.001) as evidenced from laser Doppler flowmetry and a significant decrease in fundus pulsation amplitude (-26% ± 5%; P < 0.001).
CONCLUSIONS. These results indicate that NO is continuously released in human choroidal and ONH vessels.
This article has been cited by other articles:
|
|
 |
|
  C. Simader, S. Lung, G. Weigert, J. Kolodjaschna, G. Fuchsjager-Mayrl, L. Schmetterer, and E. Polska Role of NO in the Control of Choroidal Blood Flow during a Decrease in Ocular Perfusion Pressure Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 372 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. K. Petropoulos, J.-A. C. Pournaras, A. N. Stangos, and C. J. Pournaras Effect of Systemic Nitric Oxide Synthase Inhibition on Optic Disc Oxygen Partial Pressure in Normoxia and in Hypercapnia Invest. Ophthalmol. Vis. Sci., January 1, 2009; 50(1): 378 - 384. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Huemer, G. Garhofer, T. Aggermann, J. Kolodjaschna, L. Schmetterer, and G. Fuchsjager-Mayrl Role of Nitric Oxide in Choroidal Blood Flow Regulation during Light/Dark Transitions Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4215 - 4219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Polak, A. Luksch, F. Berisha, G. Fuchsjaeger-Mayrl, S. Dallinger, and L. Schmetterer Altered Nitric Oxide System in Patients With Open-Angle Glaucoma Arch Ophthalmol, April 1, 2007; 125(4): 494 - 498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Henry, D. E. Newby, D. J. Webb, P. W. F. Hadoke, and C. J. O'Brien Altered endothelin-1 vasoreactivity in patients with untreated normal-pressure glaucoma. Invest. Ophthalmol. Vis. Sci., June 1, 2006; 47(6): 2528 - 2532. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Cleary, C H Buckley, E Henry, P McLoughlin, C O'Brien, and P W F Hadoke Enhanced endothelium derived hyperpolarising factor activity in resistance arteries from normal pressure glaucoma patients: implications for vascular function in the eye Br. J. Ophthalmol., February 1, 2005; 89(2): 223 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F Galassi, G Renieri, A Sodi, F Ucci, L Vannozzi, and E Masini Nitric oxide proxies and ocular perfusion pressure in primary open angle glaucoma Br. J. Ophthalmol., June 1, 2004; 88(6): 757 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Sato, T. Sakamoto, T. Nagaoka, F. Mori, K. Takakusaki, and A. Yoshida Role of Nitric Oxide in Regulation of Retinal Blood Flow during Hypercapnia in Cats Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4947 - 4953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. T. Dorner, G. Garhofer, K.-H. Huemer, E. Golestani, C. Zawinka, L. Schmetterer, and M. Wolzt Effects of Adrenomedullin on Ocular Hemodynamic Parameters in the Choroid and the Ophthalmic Artery Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 3947 - 3951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. T. Dorner, G. Garhofer, B. Kiss, E. Polska, K. Polak, C. E. Riva, and L. Schmetterer Nitric oxide regulates retinal vascular tone in humans Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H631 - H636. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Polska, P. Ehrlich, A. Luksch, G. Fuchsjager-Mayrl, and L. Schmetterer Effects of Adenosine on Intraocular Pressure, Optic Nerve Head Blood Flow, and Choroidal Blood Flow in Healthy Humans Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 3110 - 3114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Gugleta, S. Orgul, P. W. Hasler, T. Picornell, D. Gherghel, and J. Flammer Choroidal Vascular Reaction to Hand-Grip Stress in Subjects with Vasospasm and Its Relevance in Glaucoma Invest. Ophthalmol. Vis. Sci., April 1, 2003; 44(4): 1573 - 1580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Luksch, E. Polska, A. Imhof, J. Schering, G. Fuchsjager-Mayrl, M. Wolzt, and L. Schmetterer Role of NO in Choroidal Blood Flow Regulation during Isometric Exercise in Healthy Humans Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 734 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nagaoka, T. Sakamoto, F. Mori, E. Sato, and A. Yoshida The Effect of Nitric Oxide on Retinal Blood Flow during Hypoxia in Cats Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 3037 - 3044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Polska, A. Doelemeyer, A. Luksch, P. Ehrlich, N. Kaehler, C. L. Percicot, G. N. Lambrou, and L. Schmetterer Partial Antagonism of Endothelin 1-Induced Vasoconstriction in the Human Choroid by Topical Unoprostone Isopropyl Arch Ophthalmol, March 1, 2002; 120(3): 348 - 352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Totan, O. Cekic, M. Borazan, E. Uz, S. Sogut, and O. Akyol Plasma malondialdehyde and nitric oxide levels in age related macular degeneration Br. J. Ophthalmol., December 1, 2001; 85(12): 1426 - 1428. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
